Patients pay for high margins of pharma firms
Patients in India end up paying more for medicines and all kinds of treatment as prevailing conditions do not allow the market to function …
Online drug sale ban: Is there a need to regulate e-pharmacies?
Following an interim ban on online sale of medicines, many questions have been raised on the need for checks and balances
Child cancer drugs neither available nor accessible to the poor in Delhi
A study reveals that a lowest-paid government employee will have to spend 55 days’ wages to get a child treated for Hodgkin's lymphoma and …
Can activism check Big Pharma’s profit motives?
As prices of life-saving drugs skyrocket, people from diverse fields are getting together to fight Big Pharma
Why Modi's razzmatazz diplomacy isn't serving African interests
Missing from Modi’s foreign trips is a focus on issues most pressing for Africa’s people
After India, China rejects patent claim for hepatitis C drug Sovaldi
Activists claim that the drug was developed using previously published information and an existing compound
After cough-syrup, now eye drops: India-made solution causes 1 death, several infections in US
This could be particularly damning for India’s drug regulatory system since it is coming on the heels of cough-syrup-associated deaths in …
Indian pharma firms receive 34% of FDA warnings this year
These warnings were for misbranding, selling unapproved medicines and violating Current Good Management Practices
‘Immediate action’ needed on sub-standard drugs causing deaths: WHO
At least 300 deaths reported so far in The Gambia, Uzbekistan and Indonesia, most children
Beware of Japan's trade ambitions
Japan is pushing for higher levels of intellectual property protection that will cut access to affordable medicines
Boost to pharma production: Africa inches closer to setting up own drug regulator as member states ratify treaty
Agency will ensure drug manufacturers get approval from all African Union member states without a lengthy bureaucratic process
Lessons learnt tackling COVID-19 can be used in global AMR response: Report
Increased investment, availability and accessibility of health infrastructure and global cooperation key to tackling AMR, it says
Effective oral drug for Hepatitis C approved by European agencies
Various patent barriers hinder its availability and affordability, especially in countries with high burden of disease
Medicines Pool Swirls
Drug companies are slowly joining the UN effort to offer life-saving patented medicines to poor countries but the terms are sometimes restrictive
Vaccine hope
While Africa gets its first vaccine to fight malaria, India is still in the early stages of clinical trials
Profits and not improving accessibility matter to Indian drug makers
FICCI conference organised to discuss access to generic medicines focuses more on increasing exports
Accident at Sainor unit in Vizag more proof of companies bypassing rules
Life-saving equipments were absent on-site though the company had approvals to show they were present
AAP promises to improve health set-up and promote generic medicines in Delhi
Party says it will address health concerns of both the elderly and the young if it is voted to power
Getting the drug equation right
Sonal Matharu reports how fights over counterfeit drugs and low-quality drugs is suppressing the larger issue of drug safety
Drug pricing policies bent to favour pharma industry, allege health experts
Nearly 83 per cent medicines out of the ambit of price control policy, thus making them out of reach for most patients, say two recent reports
Obama takes first dip
The US becomes the first to join a global patents pool to make AIDS drugs cheaper but health workers are sceptical of the initiative
Mission health for all
What prime minister needs to do to make good his promise on making 12th Five-Year Plan a health plan
US authority approves more efficacious hepatitis C drug
Sofosbuvir's prohibitive cost will put it out of reach of most patients in developing countries, including India
ACTA fury goes viral
Europe is on the boil over an anti-piracy bill that will curb Internet freedom but its impact on trade in generic medicines is not on the radar
Predatory EU pacts
EU is pushing India and Canada to sign free trade agreements that will hurt their generic drugs—and the outrage is global